The Impact of Transjugular Intrahepatic Portosystemic Shunt on Nutrition in Liver Cirrhosis Patients: A Systematic Review
- PMID: 37049459
- PMCID: PMC10096634
- DOI: 10.3390/nu15071617
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Nutrition in Liver Cirrhosis Patients: A Systematic Review
Abstract
Background and aims: Liver cirrhosis leads to clinically significant portal hypertension. Transjugular intrahepatic portosystemic shunt (TIPS) has been shown to effectively reduce the degree of portal hypertension and treat its complications. However, poor nutritional status has been shown to be associated with hepatic encephalopathy, acute on chronic liver failure, and mortality following TIPS placement. The purpose of this systematic review is to create another perspective and evaluate the effect of TIPS placement on the nutritional status of patients with liver cirrhosis.
Methods: A comprehensive search of four major electronic databases was conducted to identify studies that assessed the nutritional status of cirrhotic patients before and after TIPS placement. The risk of bias was evaluated using ROBINS-I guidelines.
Results: Fifteen studies were analyzed in this review. The results indicate that among the 11 studies that evaluated changes in ascites-free weight and body mass index or body cell mass, 10 reported an improvement in one or more measures. Furthermore, all seven studies that evaluated changes in muscle mass demonstrated an increase in muscle mass. Among the four studies that evaluated subcutaneous fat tissue, three showed a significant expansion, while two out of three studies evaluating visceral fat tissue reported a significant reduction.
Conclusions: The results of this systematic review suggest that TIPS placement is associated with improvement in the nutritional status of cirrhotic patients, indicated by an increase in ascites-free weight, body mass index, and muscle mass. Additionally, TIPS placement leads to a shift in the distribution of fat mass, with a preference for subcutaneous over visceral adipose tissue. Notably, sarcopenic patients seem to benefit the most from TIPS placement in terms of nutritional status.
Keywords: fat tissue; liver cirrhosis; nutritional status; sarcopenia; transjugular intrahepatic portosystemic shunt.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Sarcopenia is a risk factor for post-transjugular intrahepatic portosystemic shunt hepatic encephalopathy and mortality: A systematic review and meta-analysis.Indian J Gastroenterol. 2024 Aug;43(4):748-759. doi: 10.1007/s12664-023-01465-2. Epub 2023 Dec 12. Indian J Gastroenterol. 2024. PMID: 38085501
-
Expanded polytetrafluoroethylene (ePTFE)-covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis.Cochrane Database Syst Rev. 2023 Aug 2;8(8):CD012358. doi: 10.1002/14651858.CD012358.pub2. Cochrane Database Syst Rev. 2023. PMID: 37531575 Free PMC article.
-
The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites.Nat Clin Pract Gastroenterol Hepatol. 2006 Jul;3(7):380-9. doi: 10.1038/ncpgasthep0523. Nat Clin Pract Gastroenterol Hepatol. 2006. PMID: 16819501
-
Identifying the optimal measurement timing and hemodynamic targets of portal pressure gradient after TIPS in patients with cirrhosis and variceal bleeding.J Hepatol. 2025 Feb;82(2):245-257. doi: 10.1016/j.jhep.2024.08.007. Epub 2024 Aug 22. J Hepatol. 2025. PMID: 39181214
-
Cardiovascular risk assessment and predictors of cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.World J Gastroenterol. 2025 Jul 21;31(27):107740. doi: 10.3748/wjg.v31.i27.107740. World J Gastroenterol. 2025. PMID: 40741106 Free PMC article.
Cited by
-
Transjugular Intrahepatic Portosystemic Shunt Placement: Effects on Nutritional Status in Cirrhotic Patients.J Clin Med. 2023 Nov 10;12(22):7029. doi: 10.3390/jcm12227029. J Clin Med. 2023. PMID: 38002642 Free PMC article. Review.
-
Comparison of clinical outcomes in patients with refractory ascites treated with either TIPS, tunneled peritoneal catheter, or ascites pump.Hepatol Commun. 2025 Jan 16;9(2):e0620. doi: 10.1097/HC9.0000000000000620. eCollection 2025 Feb 1. Hepatol Commun. 2025. PMID: 39813591 Free PMC article.
-
Role of Transjugular Intrahepatic Portosystemic Shunt in the Liver Transplant Setting.J Clin Med. 2024 Jan 21;13(2):600. doi: 10.3390/jcm13020600. J Clin Med. 2024. PMID: 38276106 Free PMC article. Review.
-
Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management.World J Gastroenterol. 2023 Dec 14;29(46):6028-6048. doi: 10.3748/wjg.v29.i46.6028. World J Gastroenterol. 2023. PMID: 38130738 Free PMC article. Review.
-
Role of Nutrition in the Management of Chronic Liver Disease.Gastro Hep Adv. 2025 Jan 2;4(5):100613. doi: 10.1016/j.gastha.2024.100613. eCollection 2025. Gastro Hep Adv. 2025. PMID: 40256313 Free PMC article. Review.
References
-
- Angeli P., Bernardi M., Villanueva C., Francoz C., Mookerjee R.P., Trebicka J., Krag A., Laleman W., Gines P. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J. Hepatol. 2018;69:406–460. - PubMed
-
- Romiti A., Merli M., Martorano M., Parrilli G., Martino F., Riggio O., Truscelli A., Capocaccia L., Budillon G. Malabsorption and nutritional abnormalities in patients with liver cirrhosis. Ital. J. Gastroenterol. 1990;22:118–123. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources